Get in touch

Submit

Thank you

 

A key aim of the patent system is to discourage inventors and innovative organisations from being secretive about their ideas and to stimulate creativity. A patent is essentially a bargain between the state and the innovator, to encourage them to disclose their work publicly so that all can benefit from and build upon technological progress. Without such incentives, innovation might take place covertly, behind a barrier of trade secrecy, or even not at all. It is easier to copy than to innovate, so patents afford protection for investors in innovation and ensure they can benefit commercially for the limited time period the patent covers.

 

In most major jurisdictions patents are assessed by technically skilled examiners appointed by national patent offices. These examiners have specialist subject knowledge and determine whether the invention that is described in the patent application and set out in statements called claims, meets the legal criteria for patentability. These criteria can vary slightly between countries but broadly they require a patentable invention to be new and non-obvious and also described sufficiently enough in the application that it enables the skilled reader to repeat the invention. Once a patent is granted, the patent owner typically receives 20 years from the filing date to enjoy the exclusivity of their patented invention before it becomes available for wider use by the public.

 

The law and processes around applying and enforcing patents can be very complex. They are driven by fixed timelines, formal legal requirements and a blend of science, law and business. Keltie’s attorneys exist to advise you on how to best navigate the system to get the best breadth of protection for your invention.

 

 

 

Image courtesy of MaximalFocus on Unsplash

MoreWorking with start-ups – interview with Dev Crease.

24.08.2020

Working with start-ups – interview with Dev Crease.

Dev Crease joined Keltie in 2004 just after he qualified as a UK and European patent attorney. Over past 16 years he has developed a thriving practice in the life sciences, chemical and medical technologies team based around advising rapid growth companies achieve value in their IP positions.

MoreIt Ain't What You Do (It's the Way That You Do It)

27.02.2021

It Ain't What You Do (It's the Way That You Do It)

Protecting Manufacturing Processes

Get in touch

Submit

Thank you